Mitochondrial biogenesis in cardiac pathophysiology
- PMID: 19307701
- DOI: 10.1016/s1734-1140(09)70015-5
Mitochondrial biogenesis in cardiac pathophysiology
Abstract
Cardiac performance depends on a fine balance between the work the heart has to perform to satisfy the needs of the body and the energy that it is able to produce. Thus, energy production by oxidative metabolism, the main energy source of the cardiac muscle, has to be strictly regulated to adapt to cardiac work. Mitochondrial biogenesis is the mechanism responsible for mitochondrial component synthesis and assembly. This process controls mitochondrial content and thus correlates with energy production that, in turn, sustains cardiac contractility. Mitochondrial biogenesis should be finely controlled to match cardiac growth and cardiac work. When the heart is subjected to an increase in work in response to physiological and pathological challenges, it adapts by increasing its mass and expressing a new genetic program. In response to physiological stimuli such as endurance training, mitochondrial biogenesis seems to follow a program involving increased cardiac mass. But in the context of pathological hypertrophy, the modifications of this mechanism remain unclear. What appears clear is that mitochondrial biogenesis is altered in heart failure, and the imbalance between cardiac work demand and energy production represents a major factor in the development of heart failure.
Similar articles
-
Transcriptional control of cardiac energy metabolism in health and disease: Lessons from animal models.Biochem Pharmacol. 2024 Jun;224:116185. doi: 10.1016/j.bcp.2024.116185. Epub 2024 Mar 30. Biochem Pharmacol. 2024. PMID: 38561091 Review.
-
Mitochondria and Cardiac Hypertrophy.Adv Exp Med Biol. 2017;982:203-226. doi: 10.1007/978-3-319-55330-6_11. Adv Exp Med Biol. 2017. PMID: 28551789 Review.
-
Cardiac insulin-resistance and decreased mitochondrial energy production precede the development of systolic heart failure after pressure-overload hypertrophy.Circ Heart Fail. 2013 Sep 1;6(5):1039-48. doi: 10.1161/CIRCHEARTFAILURE.112.000228. Epub 2013 Jul 16. Circ Heart Fail. 2013. PMID: 23861485
-
Stimulus specific changes of energy metabolism in hypertrophied heart.J Mol Cell Cardiol. 2009 Jun;46(6):952-9. doi: 10.1016/j.yjmcc.2009.01.013. J Mol Cell Cardiol. 2009. PMID: 19452634
-
Regulation of mitochondrial proliferation in the heart: power-plant failure contributes to cardiac failure in hypertrophy.Cardiovasc Res. 2004 Nov 1;64(2):198-207. doi: 10.1016/j.cardiores.2004.06.030. Cardiovasc Res. 2004. PMID: 15485678 Review.
Cited by
-
The Role of Mitophagy in Skeletal Muscle Damage and Regeneration.Cells. 2023 Feb 24;12(5):716. doi: 10.3390/cells12050716. Cells. 2023. PMID: 36899852 Free PMC article. Review.
-
The dynamic interplay between cardiac mitochondrial health and myocardial structural remodeling in metabolic heart disease, aging, and heart failure.J Cardiovasc Aging. 2023 Jan;3(1):9. doi: 10.20517/jca.2022.42. Epub 2023 Jan 3. J Cardiovasc Aging. 2023. PMID: 36742465 Free PMC article.
-
Bioactive Peptides and Exercise Modulate the AMPK/SIRT1/PGC-1α/FOXO3 Pathway as a Therapeutic Approach for Hypertensive Rats.Pharmaceuticals (Basel). 2022 Jul 1;15(7):819. doi: 10.3390/ph15070819. Pharmaceuticals (Basel). 2022. PMID: 35890118 Free PMC article.
-
Mitochondrial Quality Control in the Heart: The Balance between Physiological and Pathological Stress.Biomedicines. 2022 Jun 10;10(6):1375. doi: 10.3390/biomedicines10061375. Biomedicines. 2022. PMID: 35740401 Free PMC article. Review.
-
Milrinone effects on cardiac mitochondria, hemodynamics, and death in catecholamine-infused rats.Pediatr Res. 2022 Nov;92(5):1309-1315. doi: 10.1038/s41390-022-01964-6. Epub 2022 Feb 4. Pediatr Res. 2022. PMID: 35121850 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
